Streetbeat News

Price Targets

IONS

Guggenheim analyst Debjit Chattopadhyay maintains a Buy rating on Ionis Pharmaceuticals but lowers the price target from $70 to $65.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:15 pm

UPS

Goldman Sachs analyst Matt Reustle maintains a Buy rating on United Parcel Service (UPS) but lowers the price target from $165 to $162.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:15 pm

JBHT

Goldman Sachs analyst Jordan Alliger maintains a Buy rating on JB Hunt Transport Services but lowers the price target from $193 to $189.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:14 pm

LSTR

Goldman Sachs analyst Jordan Alliger maintains a Sell rating on Landstar System and lowers the price target from $165 to $158.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:12 pm

CHRW

Goldman Sachs analyst Jordan Alliger maintains a Neutral rating on C.H. Robinson Worldwide (NASDAQ:CHRW) but raises the price target from $90 to $97.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:11 pm

SAIA

Goldman Sachs analyst Jordan Alliger maintains a Neutral rating on Saia (NASDAQ:SAIA) and lowers the price target from $510 to $490.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:10 pm

ODFL

Goldman Sachs analyst Jordan Alliger maintains a Neutral rating on Old Dominion Freight Line (NASDAQ:ODFL) and lowers the price target from $228 to $216.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:09 pm

SNDR

Goldman Sachs analyst Jordan Alliger maintains a Neutral rating on Schneider National (NYSE:SNDR) and lowers the price target from $26 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:08 pm

KNX

Goldman Sachs analyst Jordan Alliger maintains a Neutral rating on Knight-Swift (NYSE:KNX) and lowers the price target from $48 to $44.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:07 pm

TVTX

Guggenheim analyst Vamil Divan has maintained a Buy rating on Travere Therapeutics and raised the price target from $23 to $41, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:04 pm